132 related articles for article (PubMed ID: 21527297)
1. Neuropeptide Y, an orexigenic hormone, regulates phagocytic activity of lizard splenic phagocytes.
Kumar S; Rai U
Peptides; 2011 Jun; 32(6):1324-9. PubMed ID: 21527297
[TBL] [Abstract][Full Text] [Related]
2. β-Endorphin inhibits phagocytic activity of lizard splenic phagocytes through μ receptor-coupled adenylate cyclase-protein kinase A signaling pathway.
Kumar S; Ghorai SM; Rai U
Gen Comp Endocrinol; 2011 May; 171(3):301-8. PubMed ID: 21352825
[TBL] [Abstract][Full Text] [Related]
3. Diurnal variation in phagocytic activity of splenic phagocytes in freshwater teleost Channa punctatus: melatonin and its signaling mechanism.
Roy B; Singh R; Kumar S; Rai U
J Endocrinol; 2008 Dec; 199(3):471-80. PubMed ID: 18824520
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory role of substance P in the wall lizard Hemidactylus flaviviridis: an in vitro study.
Kumar S; Rai U
Neuropeptides; 2011 Oct; 45(5):323-8. PubMed ID: 21788073
[TBL] [Abstract][Full Text] [Related]
5. Dynorphin regulates the phagocytic activity of splenic phagocytes in wall lizards: involvement of a κ-opioid receptor-coupled adenylate-cyclase-cAMP-PKA pathway.
Kumar S; Rai U
J Exp Biol; 2011 Dec; 214(Pt 24):4217-22. PubMed ID: 22116765
[TBL] [Abstract][Full Text] [Related]
6. Genomic and non-genomic effect of cortisol on phagocytosis in freshwater teleost Channa punctatus: an in vitro study.
Roy B; Rai U
Steroids; 2009; 74(4-5):449-55. PubMed ID: 19162058
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system.
Nörenberg W; Bek M; Limberger N; Takeda K; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):337-47. PubMed ID: 7543184
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.
Galas L; Tonon MC; Beaujean D; Fredriksson R; Larhammar D; Lihrmann I; Jegou S; Fournier A; Chartrel N; Vaudry H
Endocrinology; 2002 May; 143(5):1686-94. PubMed ID: 11956150
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
Herring N; Lokale MN; Danson EJ; Heaton DA; Paterson DJ
J Mol Cell Cardiol; 2008 Mar; 44(3):477-85. PubMed ID: 17996892
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y directly inhibits neuronal activity in a subpopulation of gonadotropin-releasing hormone-1 neurons via Y1 receptors.
Klenke U; Constantin S; Wray S
Endocrinology; 2010 Jun; 151(6):2736-46. PubMed ID: 20351316
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Dhillon SS; Gingerich S; Belsham DD
Regul Pept; 2009 Aug; 156(1-3):96-103. PubMed ID: 19371763
[TBL] [Abstract][Full Text] [Related]
12. Activation of extracellular signal regulated protein kinase by neuropeptide Y and pancreatic polypeptide in CHO cells expressing the NPY Y(1), Y(2), Y(4) and Y(5) receptor subtypes.
Mullins DE; Zhang X; Hawes BE
Regul Pept; 2002 Apr; 105(1):65-73. PubMed ID: 11853873
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
Ammar DA; Hughes BA; Thompson DA
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of NPY on isoprenaline-induced osteoclastogenesis in mouse bone marrow cells.
Amano S; Arai M; Goto S; Togari A
Biochim Biophys Acta; 2007 Jun; 1770(6):966-73. PubMed ID: 17383824
[TBL] [Abstract][Full Text] [Related]
15. Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway.
Kohno D; Nakata M; Maekawa F; Fujiwara K; Maejima Y; Kuramochi M; Shimazaki T; Okano H; Onaka T; Yada T
Endocrinology; 2007 May; 148(5):2251-63. PubMed ID: 17303662
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y inhibits interleukin-1β-induced phagocytosis by microglial cells.
Ferreira R; Santos T; Viegas M; Cortes L; Bernardino L; Vieira OV; Malva JO
J Neuroinflammation; 2011 Dec; 8():169. PubMed ID: 22136135
[TBL] [Abstract][Full Text] [Related]
17. Dual mode of catecholamine action on splenic macrophage phagocytosis in wall lizard, Hemidactylus flaviviridis.
Roy B; Rai U
Gen Comp Endocrinol; 2004 Apr; 136(2):180-91. PubMed ID: 15028521
[TBL] [Abstract][Full Text] [Related]
18. Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth.
Pons J; Kitlinska J; Jacques D; Perreault C; Nader M; Everhart L; Zhang Y; Zukowska Z
Can J Physiol Pharmacol; 2008 Jul; 86(7):438-48. PubMed ID: 18641693
[TBL] [Abstract][Full Text] [Related]
19. cAMP-mediated beta-adrenergic signaling negatively regulates Gq-coupled receptor-mediated fetal gene response in cardiomyocytes.
Patrizio M; Vago V; Musumeci M; Fecchi K; Sposi NM; Mattei E; Catalano L; Stati T; Marano G
J Mol Cell Cardiol; 2008 Dec; 45(6):761-9. PubMed ID: 18851973
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y inhibits adenylyl cyclase activity in rabbit retina.
Bruun A; Edvinsson L; Ehinger B
Acta Ophthalmol (Copenh); 1994 Jun; 72(3):326-31. PubMed ID: 7526593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
